Compositions and methods for treating bladder cancer
US9321820B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 14, 2010 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Oct 14, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for treating bladder cancer. In particular, the present invention provides a fusion protein comprising a toxin moiety that is linked to an epithelial growth factor (EGF) moiety. The toxin moiety and the EGF moiety can be linked optionally via a linker. Typically, the fusion protein is administered intravesically into the cancerous bladder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.